Conference Year
Conference Month

Upcoming MDPI Conferences (4)

1–15 December 2023 The 1st International Electronic Conference on Vaccines (IECV 2023)—Submission Deadline Extension


Dear Scientists, Researchers, and Authors,

We would like to inform you about the following updates on the schedule dates for the 1st International Electronic Conference on Vaccines (IECV 2023):

Abstract Submission Deadline: 15th September 2023
Notification of Acceptance Deadline: 27th September 2023
Manuscript/poster/PowerPoint/video Submission Deadline: 20th October 2023
Conference: 1–15 December 2023

You can participate in IECV 2023 free of charge in the following two ways:

- Submit Abstracts and Proceedings/Supplementary Files
Submit an abstract before 15th September 2023. After acceptance, you will be asked to submit a short proceeding paper (3–6 pages), a poster, a PowerPoint presentation (in PDF), and/or a short video presentation (max. 3–5 minutes) before 20th October 2023. Detailed information can be found at: Instructions for Authors.

- Attend Live Sessions
Throughout the duration of the conference, a number of live sessions will be held. By subscribing to IECV 2023, you will receive email notifications on the live session program and the open online discussion forum.

In addition, there are two publication options for your consideration after the conference:

- Proceedings
The accepted proceeding paper (3–6 pages) will be published with a DOI in the MDPI Medical Sciences Forum journal (ISSN 2673-9992) after plagiarism checks. The publication of proceedings papers is free of charge.

- Conference Special Issue
After the conference, authors are recommended to submit an extended version of their proceedings papers to the Vaccines (ISSN 2076-393X, IF 7.8) Special Issue "Selected Papers from the 1st International Electronic Conference on Vaccines: RNA Vaccines, Current Challenges and Future Developments (IECV2023)", for which they will receive a 20% discount on the APC.

Event Award
To acknowledge the support of the conference’s esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to launch the following awards: Best Paper Award (CHF 500) and Best Presentation Award (CHF 500). For details, please refer to

We look forward to receiving your submission and welcoming you to this e-conference.

Please do not hesitate to contact us if you have any questions.

Kind regards,
Your IECV 2023 Organizing Team
E-Mail: [email protected]

6–8 March 2024 The 4th International Electronic Conference on Cancers (IECC 2024)


The conference is organized by MDPI Cancers (ISSN: 2072-6694, Impact Factor: 5.2 (2022)) and will take place virtually on CEST 6–8 March 2024.

Conference Chairs
Dr. Angeliki Magklara, Laboratory of Clinical Chemistry, Faculty of Medicine, School of Health Sciences, University of Ioannina and Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology-Hellas, Greece
Dr. Shinji Kawabata, Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Japan
Prof. Dr. Alfredo Conti, Unit of Neurosurgery, IRCCS Istituto delle Scienze Neurologiche di Bologna, Italy
Prof. Vasso Apostolopoulos, Institute for Health and Sport, Victoria University, Australia

The Topics of Interest
SESSION A. Brain Metastases
SESSION B. Cancer Biomarkers
SESSION C. Cancer Immunology and Immunotherapy
SESSION D. Tumor Microenvironment
SESSION E. Molecular Cancer Biology
SESSION F. Cancer Epidemiology and Prevention
SESSION G. Cancer Therapy
SESSION H. Cancer Pathophysiology

Important Dates
Deadline for abstract submission: 15 December 2023
Notification of acceptance: 20 January 2024
Deadline for Early Bird Registration: 26 January 2024

Guide for Authors
To submit your abstract, please click on the following link:
To register for the event, please click on the following link:
For details regarding Abstract Submission, Poster and Slides Submission, Publication Opportunities, you may refer to “Instructions for Authors”.

For any enquiries regarding the event, please contact: [email protected]

We look forward to seeing you at the 4th International Electronic Conference on Cancers.

23–25 April 2024 The 3rd International Electronic Conference on Biomolecules


The conference is organized by the MDPI journal Biomolecules and will take place virtually on 23–25 April 2024 (Central European Time)

Conference Chair:
Prof. Dr. Vladimir N. Uversky
Department of Molecular Medicine, University of South Florida, USA

The Topics of Interest

  1. Biomolecular Structures and Functions
  2. Molecular Mechanisms in Cellular Processes
  3. Biomolecular Interactions and Networks
  4. Biomaterials Design and Characterization
  5. Biocatalysis and Enzyme Engineering
  6. Bioinformatics and Computational Biology

Important Dates
Deadline for abstract submission: 23rd January 2024
Notification of acceptance: 23rd February 2024
Deadline for Early Bird Registration: 27th February 2024

Guide for Authors

To submit your abstract, please click on the following link:

To register for the event, please click “Event Registration” on the homepage.

For details regarding submission of abstracts, posters, and slides, as well as publication opportunities, please refer to “Instructions for Authors”.

For any enquiries regarding the event, please contact: [email protected].

We look forward to seeing you at the 3rd International Electronic Conference on Biomolecules.

10–12 July 2024 The 1st International Online Conference on Functional Biomaterials


We cordially invite you to attend this event organized by MDPI’s Journal of Functional Biomaterials (ISSN 2079-4983, Impact Factor 4.8). It will take place virtually on 10–12 July 2024, online.

Conference Chair
Prof. Dr. Pankaj Vadgama, School of Engineering and Materials Science, Queen Mary University of London, UK.

Topics of Interest:

  1. Dental biomaterials;
  2. Bone biomaterials;
  3. Antibacterial biomaterials;
  4. Biomaterials for tissue engineering;
  5. Biomaterials for drug delivery;
  6. Biomaterials for diagnostics, therapy and healthcare;
  7. Bio-fabricated and 3D-printed biomaterials.

Important Dates

  • Deadline for abstract submission: 10th March 2024
  • Notification of acceptance: 10th April 2024
  • Deadline for Early Bird Registration: 15th April 2024
  • Registration deadline: 4th July 2024

Guide for Authors

For any enquiries regarding the event, please contact: [email protected]

We look forward to seeing you at the 1st International Online Conference on Functional Biomaterials.

Cancers announces selected third-party conferences. In case you would like to announce your own event on the Cancers website, please fill out the following form to apply for the announcement of a conference or other academic event (seminar, workshop).

Conference Year
Conference Month

Upcoming Partner Conferences (6)

5–7 December 2023 Flash Radiotherapy and Particle Therapy 2023 Conference

Toronto, Canada, and online

Flash Radiotherapy and Particle Therapy (FRPT 2023) will be the third multidisciplinary forum for the latest research on FLASH and Particle Therapy.

It will take place on 5–7 December 2023 in Toronto, Canada, and online.

FRPT 2023 looks to build a worldwide organisation of scientists and professionals interested in FLASH Radiotherapy using protons, electrons, heavier charged ions, and photons.

We will bring together researchers and students with professionals working in clinical oncology (clinicians, medical physicists, dosimetrists, radiotherapy technologists, and nurses) and industry, and provide a multidisciplinary forum to discuss the latest developments in FLASH Radiotherapy.

FRPT includes everything from basic science to preclinical research and combines these with translational applications and clinical trials and treatment.

Throughout the conference, we will discuss all modalities related to FLASH-RT with the best international experts in the field: clinical trials, protocols, mechanism, new horizons, and more. Participants will have access to the very latest progress on FLASH clinical devices, metrology and dose monitoring, treatment planning systems, modelling, physio-chemistry, biological mechanisms, preclinical studies, and clinical trials.

The ultimate goal of FRPT is to harness the potential for FLASH Radiotherapy in a rigorous scientific and quality-assured environment and to act as a forum for the very latest advancements in this rapidly developing field.

Late-Breaking Abstract Submission Deadline: 11 September 2023

Abstract submitters will be able to submit abstract(s) in the following abstract categories:

  • Oral presentation;
  • E-Poster presentation (oral E-Poster);
  • E-Poster Viewing.

Learn more about Abstract Submission here:

Early Bird Registration Deadline: 9 August 2023

Learn more about registration here: 

We look forward to receiving your abstracts and welcoming you to this conference so that we can revolutionise cancer treatment together!

Please do not hesitate to contact us if you have any questions.

Email: [email protected]

22–23 February 2024 Cancer Care 2024 Nursing CNE Conference

Orlando, FL, USA

This course offers Live (in person) and Livestream (virtual) attendance options.

22–23 February 2024, Margaritaville Resort, Orlando, FL, USA, 7:00 a.m., Eastern Time Zone.

This Mayo Clinic Cancer Care 2024 Nursing CNE Conference provides an overview of many aspects of oncology care, including pharmacy updates, integrative therapies, nutrition, radiation therapy, pharmacogenomics, supportive services, ethics, updates to CAR-T, sexual health, home infusion programs, caring for diverse populations, and powerful patient stories.

Target Audience

This CNE conference is designed for nurses, social workers, and other healthcare professionals involved in the care of individuals with cancer and their families.

Learning Objectives

Upon completion, the participants should be able to:

  • Describe the concepts of oncological care.
  • Identify updates in clinical and pharmacology therapies.
  • Outline the role of the nurse in oncology care.

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge, or performance of any care or procedure(s) which may be discussed or taught in this course.

Credit Statements 
The Mayo Clinic College of Medicine and Science designates estimates it will last for a maximum of 15.25 ANCC contact hours.



As a Jointly Accredited Organization, the Mayo Clinic College of Medicine and Science is approved to offer social work education via the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 15.25 general continuing education credits.


Accreditation Statement
In support of improving patient care, the Mayo Clinic College of Medicine and Science is jointly accredited with the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for healthcare teams.

13 April 2024 CMC 2024 Distilled—Update in Women’s Cancer


In 2024, you can experience a continuation of the one-day online update, which now takes place every two years between the traditional meetings in Berlin. The scientific committee has “distilled”—as the subheading says—the crucial aspects of women’s cancer management.

The clinical and scientific update covers highlights in breast, ovarian, cervical, and endometrial cancer. An exclusive agenda with presidential lectures, state-of-the-art sessions, pro/con debates, and educational lectures will be prepared.

Leading experts from all over the world will present to you a specific program with great significance for your clinical and scientific work.

After the phenomenal success of the premiere in 2022, with more than 1,700 participants from 100 countries and the great feedback, the conference chairs are looking forward to a global dialogue in 2024.


22–24 April 2024 The 4th Symposium on World Cancer Research (SWCR 2024) Hybrid


The organizing committee sincerely welcomes you to join The 4th SYMPOSIUM ON WORLD CANCER RESEARCH (SWCR 2024), which will be held on Apr. 22nd–24th, 2024, in Singapore.

SWCR 2024 includes a plenary forum, 15 breakout streams, and a poster exhibition in the three-day scientific program. The topics will focus on Cancer Genetics and Genomics, Cancer Screening and Early Detection, Cancer Therapy and Treatment, Cancer Metastasis, Tumor Microenvironment, and different kinds of cancers/tumors, such as Lung Cancer, Breast Cancer, etc.

SWCR 2024 is planned as a hybrid event. We are hopeful that many of you will be able to make the trip to the beautiful country to see old colleagues and make new friends.

25–28 April 2024 96th SIBS Congress

L’Aquila, Italy

It is with great pleasure that we inform you that the 96th National Congress will be held in L’Aquila, from 25 to 28 April 2024, at the Palazzo dell’Emiciclo, headquarters of the Regional Council of the Abruzzo Region (in via Michele Iacobucci, 4), as approved by our Board of Directors.

The location of the Palazzo dell’Emiciclo is central and reachable on foot from hotels, B&Bs, and holiday homes in the center. The main monuments and places of interest in L’Aquila are in fact all located in the historic center.

The official language of the congress will, as always, be Italian. The scheduled sessions will be in sequence to allow everyone to follow the scientific works. There will be masterly readings with prestigious speakers. If the contributions received do not allow everyone to have space for oral communication, one or more video poster sessions will also be organized.

The scientific sessions, for which you are invited to send your contributions, will deal with the following topics:


Environment and health;

Aquatic environments;


Applied biochemistry;

Biodiversity and modeling;

Urban biodiversity and climate change;

Biology of reproduction and infertility;

Structural biology;

Plant biology;

Biomedical and pharmaceutical biotechnology;

Artificial intelligence applied to biomedicine;

Precision medicine;

Regenerative medicine;

Micro- and nanovesicles in biomedicine;

Advanced microscopy and imaging;



Nutrition and food supplements;


Cellular stress.

Based on the number of contributions received, some themes may be merged with others and renamed.

For further information, we invite you to periodically consult the website, which will be constantly updated.

With the hope of meeting many of you in L’Aquila to discuss the most up-to-date topics in experimental biology—also in the organizational phase—we send you our warmest regards.

29–31 May 2024 The 8th Cancer World Congress

Dubrovnik, Croatia

The Cancer World Congress is a series of oncology conferences held annually, with its prime focus being a cancer-free society through the promotion of the latest advances in cancer research, prevention, diagnosis, treatment, and care interventions.

The 8th Cancer World Congress-2024 will take place on 29–31 May 2024, in Dubrovnik, Croatia. This cancer conference runs on the theme "New Frontiers in Oncology Research and Practice"

We would be grateful if you could join us and give an oral presentation of your recent research, or attend as a delegate. Special discounts are available for this journal’s (Cancers ISSN 2072-6694) editorial board members and authors.

Back to TopTop